Aurora Cannabis is trading down after reporting its Q1 results
Shares of Aurora Cannabis Inc (NASDAQ: ACB) are trading down in extended hours after the cannabis company reported disappointing results for its fiscal first quarter.
CEO Miguel Martin’s remarksCopy link to section
On the bright side, though, the Canadian company reiterated its commitment to positive adjusted EBITDA by the end of 2022. In the earnings press release, CEO Miguel Martin also said:
We’re on track to achieving up to $170 million in annualised cost savings by Dec 31st. Our strengthened balance sheet and strong cash position has facilitated early repurchases of convertible debt of C$213 million.
Aurora Cannabis ended the quarter with C$393 million in cash. It’s noteworthy of those interested in buying Aurora Cannabis stock that the Wall Street currently rates it at “hold”.
Notable figures in Aurora Cannabis’ Q1 resultsCopy link to section
- Lost C$51.9 million versus the year-ago C$11.9 million
- Revenue tanked 18% year-on-year to C$49.3 million
- Consensus was C$33.7 million loss on C$52.6 million sales
Medical and recreational cannabis sales were down 23% and 28% versus last year, respectively. Sequentially, though recreational cannabis was up 9.0%. A day earlier, two more U.S. states voted to legalise recreational marijuana.
Looking to invest?
Invest globally in stocks, options, futures, currencies, bonds and funds from a single unified platform, with our highest-rated broker.
What contributed to the weak Q1 performanceCopy link to section
Aurora narrowed its net loss on a quarter-over-quarter basis as well; though revenue was in the red even sequentially. CEO martin added:
Are you looking for fast-news, hot-tips and market analysis? Sign-up for the Invezz newsletter, today.
Through profitable growth opportunities, particularly in our high-margin global medical cannabis business, disciplined capital deployment, and completion of cost structure rationalisation, we’re well-positioned to enhance long-term value of our company.
Aurora Cannabis Inc blamed cyberattack at its online Ontario Cannabis store and strike in British Columbia that pushed it into temporarily closing stores for the weak performance in Q1. Its $38 million acquisition of Thrive Cannabis, however, did help on the sales front.
The cannabis stock is now down more than 75% for the year.
Copy expert traders easily with eToro. Invest in stocks like Tesla & Apple. Instantly trade ETFs like FTSE 100 & S&P 500. Sign-up in minutes.
eToro offers real assets only, no CFD products. eToro USA LLC and eToro USA Securities Inc.; Investing involves risk, including loss of principal; Not a recommendation.